ProCE Banner Activity

RABBIT: Risk of Herpes Zoster Stratified by DMARD Type Among Patients With Rheumatoid Arthritis

Slideset Download
Conference Coverage
Among patients receiving DMARDs for RA, risk of herpes zoster was significantly higher with JAK inhibitors, monoclonal TNF inhibitor antibodies, B-cell­–targeted therapy, T-cell costimulation modulation, or IL-6 inhibition.

Released: July 01, 2020

Expiration: June 30, 2021

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AbbVie Inc.

Gilead Sciences, Inc.